Genmab reported 140.03B in Market Capitalization this May of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Agios Pharmaceuticals AGIO:US $ 1.78B 0.94B
Almirall ALM:SM 2.03B 438.03M
Argen X Bv ARGX:BB 15.15B 912.65M
AstraZeneca AZN:LN 134.46B 4.31B
Bayer BAYN:GR 46.28B 97.26M
Bluebird Bio BLUE:US $ 0.7B 0.59B
Fresenius Medical Care FME:GR 16.78B 1.05B
Galapagos GLPG:NA 3.23B 267.16M
Genmab GEN:DC 162.03B 11.18B
GRIFOLS GRF:SM 13.6B 337.76M
Hikma Pharmaceutical HIK:LN 5.14B 525.22M
Immunogen IMGN:US $ 1.05B 0.54B
Lonza Group LONN:SW 56.72B 7.88B
Novartis NOVN:VX 195.44B 8.4B
Sanofi SAN:FP 111.92B 6.96B
UCB UCB:BB 19.52B 2.37B
William Demant Holding WDH:DC 80.64B 4.12B